HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.

Abstract
Single and multiple high-dose administrations of methamphetamine (METH) differentially decrease dopamine (DA) transporter (DAT) function, as assessed by measuring [(3)H]DA uptake into rat striatal synaptosomes prepared 1 h after treatment. Prevention of METH-induced hyperthermia attenuated the decrease in DAT activity induced by multiple injections of the stimulant. Likewise, this decrease was attenuated by previous depletion of striatal DA levels using alpha-methyl-p-tyrosine (alphaMT) or pretreatment with the D1 and D2 antagonists SCH-23390 and eticlopride, respectively. However, METH-induced hyperthermia was also blocked by alphaMT and eticlopride. Reinstatement of hyperthermia to alphaMT- or eticlopride-pretreated rats partially restored the METH-induced decrease in DAT activity. In contrast, neither prevention of METH-induced hyperthermia depletion of DA, nor DA antagonists altered the decrease in DAT function induced by a single administration of METH. Pretreatment with the antioxidant N-t-butyl-alpha-phenylnitrone prevented part of the decrease in DAT function associated with multiple, but not a single, METH injections. Although not tested directly, additional data presented here suggest that the reduction in DAT activity induced by a single METH administration constitutes a part of the total reduction observed immediately after multiple administrations. Taken together, the results indicate that DA, hyperthermia, and oxygen radicals contribute to a component of the rapid decrease in DAT function induced by multiple injections of METH but do not appear to be associated with the reduction induced by a single administration of the stimulant.
AuthorsR R Metzger, H M Haughey, D G Wilkins, J W Gibb, G R Hanson, A E Fleckenstein
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 295 Issue 3 Pg. 1077-85 (Dec 2000) ISSN: 0022-3565 [Print] United States
PMID11082443 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carrier Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Reactive Oxygen Species
  • Receptors, N-Methyl-D-Aspartate
  • Slc6a3 protein, rat
  • Serotonin
  • Methamphetamine
  • Dopamine
Topics
  • Animals
  • Carrier Proteins (drug effects, physiology)
  • Dopamine (physiology)
  • Dopamine Plasma Membrane Transport Proteins
  • Fever (physiopathology)
  • Male
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Methamphetamine (pharmacology)
  • Nerve Tissue Proteins
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species
  • Receptors, N-Methyl-D-Aspartate (physiology)
  • Serotonin (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: